A new study aims to address racial disparities by examining the role of decision-making in Black patients’ attitudes about prostate cancer screening.
The phase 3 SWOG S1216 trial has set a new benchmark for survival estimates for metastatic hormone-sensitive prostate cancer patients who have access to multiple approved subsequent life-prolonging therapies.
Findings from a new study show that pharmacologically inhibiting the H6PD protein can reverse drug resistance in human-derived preclinical models of enzalutamide-resistant prostate cancer.
Learn more about examples of groundbreaking research and new medical and surgical approaches that are leading the way in prostate cancer care.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
An article published in the Cleveland Clinic Journal of Medicine outlines current guidelines in prostate cancer screening from the lens of a urologist practicing in the UK.
The decision to screen for prostate cancer is a complicated one. A Cleveland Clinic medical oncologist discusses overdiagnosis and recommends a new path forward.
When used with positron emission tomography, the agent rhPSMA-7.3 (18F) tags prostate-specific membrane antigen, a protein on the surface of the cancer cells, and identifies it on the scan.
Androgen-receptor (AR) antagonists can alter the metabolism of patients with prostate cancer, shows a recent study. And a transporter protein may become a new therapeutic target for kidney cancer.
Cleveland Clinic is now offering the IsoPSA™ test, a novel prostate-specific antigen assay, for patients with a PSA > 4ng/ml who are facing a decision on prostate biopsy.
A new test developed at Cleveland Clinic interrogates the HSD3B1 gene to determine if a prostate cancer patient has inherited the adrenal-permissive (1245C) or adrenal-restrictive (1245A) allele. The development of the test is an outgrowth of more than seven years of research at Cleveland Clinic.